Nicoloso Milena S, Kipps Thomas J, Croce Carlo M, Calin George A
Department of Experimental Therapeutics, University of Texas, MD Anderson Cancer Center, Houston, TX, USA.
Br J Haematol. 2007 Dec;139(5):709-16. doi: 10.1111/j.1365-2141.2007.06868.x.
MicroRNAs (miRNAs) have been linked to the initiation and progression of chronic lymphocytic leukaemia (CLL). The main molecular alterations are represented by variations in gene expression, usually mild and with consequences for a vast number of target protein-coding genes. Recent studies have shown that miRNAs are the main candidates for the elusive class of CLL predisposing genes. These discoveries could be exploited for the development of useful markers for diagnosis and prognosis, as well as for the development of new RNA-based cancer therapies.
微小RNA(miRNA)与慢性淋巴细胞白血病(CLL)的发生和发展有关。主要的分子改变表现为基因表达的变化,通常较为轻微,但会对大量靶蛋白编码基因产生影响。最近的研究表明,miRNA是难以捉摸的CLL易感基因类别的主要候选者。这些发现可用于开发诊断和预后的有用标志物,以及开发新的基于RNA的癌症疗法。